Biotech Funding

'People talk about the financing gap, but most of the time, the most important gap is the information gap. You need to inform…

When no one worried about IT spending, startups leaned into the bottom-up sales approach and driving PLG. But that was then, and…

In this week's edition of Week in Review, we cover the new ChatGPT mobile app, a startup building humanoid robots and free TVs --…

TechCrunch Live had some amazing shows over the last few months. I know it’s hard to keep up. Every Wednesday, at 12:00pm PDT,…

How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look.

Pale Blue Dot looks to make pre-seed and seed investments in European-based climate tech-oriented startups, although it is open…

On a balmy day in mid-April, thousands of people queued in line to enter the Hong Kong Convention Center where the city’s…

Reducing CAC Payback and following the Rule of 40 is proof that a founding team knows how to move directionally. Investors love…

The market may be be tightening, but not for Eclipse Ventures, a Palo Alto-based venture firm that just raised $1.2 billion…

Welcome to Startups Weekly, a nuanced take on this week’s startup news and trends by Senior Reporter and Equity co-host Natasha…

"Growth at all costs" is a fairy tale made possible by cheap money that helped VCs set expectations for founders — and each other.

Stability AI, the company behind Stable Diffusion, is backing a community effort to apply AI techniques to biomedicine.

Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single…

San Francisco is no longer the center of the startup universe, and it hasn’t been for a while.

Form Bio was incubated within Colossal Biosciences and now is hoping to bring its workflow systems to other computational biology…

Welcome to Startups Weekly, a fresh human-first take on this week’s startup news and trends. To get this in your inbox, subscribe…

Based in Japan, biotech startup Dioseve’s ambitious goal is to grow human oocytes, or eggs, from other tissue. Its aim is to help…

"Longevity tech is only getting started now and will infiltrate all aspects of our life in the next five to 10 years."

Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a…

Unlike CEO Elizabeth Holmes, Balwani was indicted for defrauding patients, as well as investors.